Quick Guide to Recent Changes We’ve Made to G2’s Reports
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
News
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Subscribe today for access to
Articles and Reports
A New Tool for Helping Labs Improve Diversity in Clinical Trials
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Expert Q&A: Key Developments in AI and Digital Pathology
Juan Antonio Retamero, MD, shares his thoughts on recent trends in AI and digital pathology, and how they may progress.
Should Certain Racial Groups be Screened for Diabetes at Lower BMIs?
Recent study shows that different diabetes screening guidelines are required to produce equal benefits for certain racial groups.
Labs in Court Weekly Roundup
Recent health care industry-related cases involved a variety of fraud types, including kickbacks and fake vaccine card distribution.
World Leaders Promise More Funds to Fight Pandemic at COVID-19 Summit
Meeting for the second Global COVID-19 Summit, leaders from around the world made additional financial commitments to fighting the disease
Lab Compliance Will Change When the Public Health Emergency Ends
The relaxed regulatory environment labs have provided during the COVID-19 pandemic is set to come to and end soon.
Millions Will Lose Medicaid Coverage When the PHE Ends: Report
New report says between 5.3 and 14.2 million people will lose their Medicaid coverage when the COVID-19 public health emergency ends.
New Resource Aims to Improve Diagnosis of Patients with Hearing Loss
Guidance from the American College of Medical Genetics and Genomics shares the importance of a genetic evaluation for hearing loss.
FDA Recalls More COVID-19 Tests
Recall of Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test the latest in string of recent Class I events.
Recent Recall a Reminder to Check Which COVID-19 Tests Your Lab Can Use
Celltrion’s recall was labeled by the FDA as Class I, due to the kits possibly being distributed to non-CLIA certified users.
OIG Green Lights Free Genetic Testing Arrangement
The OIG recently issued an Advisory Opinion approving a proposed arrangement involving the offering of free genetic tests.
Labs in Court Weekly Roundup
False and fraudulent claims and billing were the theme in key enforcement actions relating to the health care industry announced last week.
